These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7995584)

  • 21. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult].
    Jung HK; Lee DS
    Korean J Gastroenterol; 2014 Jun; 63(6):378-81. PubMed ID: 24953617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ceftriaxone-induced cholelithiasis].
    Maccherini M; Borlini G; Branchi M; Barbonetti C; Moretti P; Bonora G
    Pediatr Med Chir; 1998; 20(5):341-3. PubMed ID: 10068984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children.
    Schaad UB; Suter S; Gianella-Borradori A; Pfenninger J; Auckenthaler R; Bernath O; Cheseaux JJ; Wedgwood J
    N Engl J Med; 1990 Jan; 322(3):141-7. PubMed ID: 2403654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Symptomatic pseudolithiasis caused by Rocephalin].
    Tuckuviene R; Myrtue GS
    Ugeskr Laeger; 2000 Aug; 162(32):4271-2. PubMed ID: 10962947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults.
    Yoshida R; Yoshizako T; Katsube T; Kitagaki H
    Jpn J Radiol; 2019 Dec; 37(12):826-831. PubMed ID: 31654330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.
    Kirejczyk WM; Crowe HM; Mackay IM; Quintiliani R; Cronin EB
    AJR Am J Roentgenol; 1992 Aug; 159(2):329-30. PubMed ID: 1632349
    [No Abstract]   [Full Text] [Related]  

  • 29. Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate.
    Park HZ; Lee SP; Schy AL
    Gastroenterology; 1991 Jun; 100(6):1665-70. PubMed ID: 2019372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary precipitation during ceftriaxone therapy: frequency and risk factors.
    Soysal A; Eraşov K; Akpinar I; Bakir M
    Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract infection.
    Krzemień G; Książczyk T; Szmigielska A; Bombiński P; Roszkowska-Blaim M; Werner B; Brzewski M
    Dev Period Med; 2015; 19(2):182-5. PubMed ID: 26384120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature.
    Bickford CL; Spencer AP
    Pharmacotherapy; 2005 Oct; 25(10):1389-95. PubMed ID: 16185184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy.
    Blais C; Duperval R
    Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible ceftriaxone-associated biliary pseudolithiasis in children.
    Schaad UB; Wedgwood-Krucko J; Tschaeppeler H
    Lancet; 1988 Dec; 2(8625):1411-3. PubMed ID: 2904533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
    Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.
    Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD
    Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echogenic material in the fetal gallbladder: sonographic and clinical observations.
    Brown DL; Teele RL; Doubilet PM; DiSalvo DN; Benson CB; Van Alstyne GA
    Radiology; 1992 Jan; 182(1):73-6. PubMed ID: 1727312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone-induced symptomatic cholelithiasis in a child: case report and literature review.
    Smerat MI; Shawer B; AbuIrayyeh BM; Natsheh ST; Diab L; Shahin FB; Manasra MR
    Oxf Med Case Reports; 2024 Jun; 2024(6):omae062. PubMed ID: 38860015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transient biliary lithiasis associated with the use of ceftriaxone].
    Alvarez-Coca González J; Cebrero García M; Vecilla Rivelles MC; Alonso Cristobo M; Torrijos Roman C
    An Esp Pediatr; 2000 Oct; 53(4):366-8. PubMed ID: 11083990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.